FRIDAY, April 29, 2022 (HealthDay News) — There were significant reductions in the prevalence of self-reported cigarette smoking among U.S. adults with major depressive episode (MDE), substance use disorder (SUD), or both between 2006 and 2019, according to a study published in the April 26 issue of the Journal of the American Medical Associationn.
Beth Han, MD, Ph.D., of the US National Institutes of Health in Bethesda, Maryland, and colleagues assessed the change in cigarette smoking prevalence among US adults with MDE, SUD, or both between 2006 and 2019. The analysis included data from 558,960 adults who participated in the US national surveys from 2006 to 2019 on drug use and health.
The researchers found that self-reported past month cigarette smoking prevalence decreased significantly among adults with MDE, adults with SUD, and adults with concomitant MDE and SUD. Significant decreases were seen in age, gender, and racial and ethnic subgroup with MDE and with SUD, except in American Indian or Alaskan adults with MDE or with SUD. Differences in cigarette smoking prevalence between adults with versus without MDE decreased significantly for adults overall (mean annual percentage change, −3.4); differences between those with versus without substance abuse treatment decreased for women (mean annual percentage change, −1.8).
“These declines tell a public health success story,” a co-author said in a statement. “It is critical that health care providers treat all health problems a patient is experiencing, not just their depression or substance use disorder at any given time. To do this, smoking cessation therapies must be integrated into existing behavioral health treatments.”
Summary/Full Text (subscription or payment may be required)